Corporate Banner
Satellite Banner
Technology Networks Header
Friday, April 18, 2014
 
Register | Sign in
Home Page>Products
  Product News
Dolomite Continues to Release the Coolest Microfluidic Products
Friday, March 21, 2014
Dolomite planned to release Dropix in April 2014.

A New Tool for Pharmaceutical Companies Technology Transfer from Cornell University
Friday, March 21, 2014
High pressure cryo-cooler for X-ray crystallography from ADC.

JBS Publication Demonstrates Utility of InSphero 3D Co-Culture Microtissues as Phenotypic RNAi Screening Tool
Friday, March 21, 2014
Report in the Journal of Biomolecular Screening establishes fluorescent 3D tumor co-culture model, enables screening of gene function in a system more reflective of in vivo tumor growth.

Sapio Sciences Announces Exemplar NGS LIMS for Next Gen Sequencing Labs
Thursday, March 20, 2014
Exemplar NGS provides pre-built, clinical standard workflows for leading NGS platforms

Autoscribe Announces a New Concept in Screen Saving from Matrix Gemini LIMS
Thursday, March 20, 2014
New screen saving feature enables automatic audit trails.

Driving Petroleum Research Forward with a Syrris CRS
Thursday, March 20, 2014
Collaboration with KISR to manufacture custom reactor system.

Syngene Expands its Range of Imaging Systems
Thursday, March 20, 2014
For fast, accurate imaging of 2D or 1D gels and all blot types.

Repeat Liquid Dispensing with Ease - Whatever Users Sample
Thursday, March 20, 2014
New Ripette® genX dispenser from Alpha Laboratories.

ChromaTrap Receives Positive Commentary in Cited Research
Thursday, March 20, 2014
Researchers cite how using the fast, sensitive ChIP technology has benefited their research.

<< 10 11 12 13 14 15 16 >>
Showing Results 121 - 130 of 10008
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv